ATRX and central nervous system cancer: To assess this possibility, we used three genetically modified mouse ES cell lines—H3.3 K27M, H3.3 G34R, and an H3.3 G34R/ATRX KO double mutant (DM) that recapitulates the mutation combination that is frequently observed in pediatric gliomas [19].